Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · Real-Time Price · USD

12.75

-0.08 (-0.62%)

At close: Oct 30, 2026, 4:00 PM EDT

12.50

-0.25 (-1.96%)

After-hours: Oct 30, 2026, 7:30 PM EDT

IART Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	992	967	1,750	3,405	4,683	5,674
Market Cap Growth	-17.49%	-44.72%	-48.60%	-27.30%	-17.47%	3.71%
Enterprise Value	2,683	2,707	3,464	4,800	5,872	6,918
Last Close Price	12.75	12.42	22.68	43.55	56.07	66.99

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	75.92	-	-	50.26	25.94	33.56
Forward PE	5.47	5.21	8.83	12.94	16.16	20.19
PS Ratio	0.60	0.59	1.09	2.21	3.01	3.68
PB Ratio	0.93	0.93	1.13	2.14	2.60	3.37
P/FCF Ratio	11.56	-	70.10	46.58	21.08	21.46
P/OCF Ratio	7.07	19.20	13.53	24.33	17.71	18.16
PEG Ratio	1.24	18.37	6.17	1.54	1.68	1.36

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.62	1.66	2.15	3.11	3.77	4.49
EV/EBITDA Ratio	8.44	9.09	10.73	20.42	16.44	21.63
EV/EBIT Ratio	16.39	18.55	19.04	43.04	24.58	34.59
EV/FCF Ratio	31.28	-	138.75	65.68	26.44	26.16

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.88	1.95	1.29	1.06	0.90	1.01
Debt / EBITDA Ratio	5.83	6.33	5.72	6.50	4.25	5.00
Debt / FCF Ratio	23.35	-	79.57	23.03	7.27	6.43
Net Debt / Equity Ratio	1.59	1.70	1.11	0.87	0.64	0.70
Net Debt / EBITDA Ratio	5.32	5.95	5.31	5.85	3.24	3.71
Net Debt / FCF Ratio	19.72	-57.04	68.61	18.80	5.22	4.49
Asset Turnover	0.46	0.43	0.41	0.40	0.41	0.42
Inventory Turnover	1.55	1.55	1.59	1.84	1.83	1.91
Quick Ratio	1.71	1.19	0.59	1.85	2.24	2.23
Current Ratio	3.62	2.54	1.17	3.45	3.62	3.39
Return on Equity (ROE)	1.24%	-39.90%	-0.44%	3.99%	10.35%	10.57%
Return on Assets (ROA)	2.86%	2.39%	2.91%	1.82%	3.89%	3.38%
Return on Invested Capital (ROIC)	3.43%	4.81%	5.85%	3.15%	6.91%	5.56%
Return on Capital Employed (ROCE)	5.20%	4.60%	5.80%	3.20%	6.70%	5.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.32%	-53.39%	-0.40%	1.99%	3.86%	2.98%
FCF Yield	8.65%	-3.21%	1.43%	2.15%	4.74%	4.66%
Buyback Yield / Dilution	-1.38%	0.44%	4.14%	3.81%	2.30%	-0.30%

SEC Filings: 10-K · 10-Q